7Mo·

What do you think about the current situation of $NOVO B (+2,52 %) ? In my opinion, it is one of the most attractive EU shares and currently also very cheap. In my opinion, we will see a solid bottom formation for the first time in the near future and then a clear + from the current price. But I don't think it will be enough for a new ATH as I expect a recession in Q1 2025. But who knows? December should still be very bullish in any case 😁 However, in my opinion you can definitely take a few % with you now and for long-term investors it is also a nice entry price at the moment.

Do you think we will still go below €90 or are we now forming a bottom?

Have a nice Sunday everyone 👋🏻

9 Commentaires

Francescoo@Francescoo

7Mo

Definitely an interesting value.
However, it is still highly valued.
I have already considered adding the first tranche to my portfolio.
But will wait a little longer for now.

•

Aktienmaurer👷‍♂️📈🦍@Aktienmaurer

7Mo

I bought a first tranche on Friday. The share has always outperformed me. Dividend + dividend growth and the share price performance are right for me here.
I could imagine that the €90 mark will be approached, but I don't believe that Novo will fall significantly lower. In that case, I would of course buy the next tranche nachlegen💪🏽

•

Kate🦋@Iwamoto

7Mo

Very risky, in my opinion. At the moment, the long-term upward trend still seems to be intact. However, should the price fall below DKK 690, the upward trend would be broken in my view.

(DKK 690 is roughly €92.50, which corresponds to -4.5% of the current price)

•

Imvestment4Life@Investment4Life

7Mo

@Iwanowitsch convert into roubles. You can see an upward trend

•

Sparfuchs@Reinecke

7Mo

Such companies should be valued according to the pipeline and not the fundamentals. I am rather keen on Biontech at the moment.

••

Gomerdoc@Gomerdoc

7Mo

@Reinecke If you are judging by the pipeline, and a realistic pipeline at that: Then Novo (! sic) or Amgen. Certainly not Biontech. They make all their sales with corona vaccines, and everything else so far is science fiction that hasn't even found its way into a Phase 3 trial.... See Curevac/Heidelberg. They've been in business even longer, but this business is difficult...

••

Sparfuchs@Reinecke

7Mo

@Gomerdoc He has Amgen and if one of the 8 Sience Fiction products works, Biontec will quickly be at 500. Thanks to Corona, liquidity is no longer a problem.

••

Gomerdoc@Gomerdoc

7Mo

@Reinecke and as soon as that happens: Amgen buys Biontech 😉

••

Sparfuchs@Reinecke

7Mo

@Gomerdoc I still have enough $AMGN in my US custody account that I don't care if they offer me 500 euros per share for my $BNTX in the German custody account. They just can't do shit like $HALO.

••